Munich Innovation to Acquire Bone & Tissue Regeneration Technology Portfolio

Munich Innovation, based in Germany, plans to acquire the Magnetodyn patented portfolio of bone and tissue regeneration technology.

Advertisement

The portfolio includes technology from 10 different patent families, which includes 31 granted patents and 29 active patent applications in the United States, Europe and worldwide.

 

The Magnetodyn technology is designed for use in orthopedics, trauma, wound care and infection control.

 

More Articles on Devices:
Mainstay Medical International Requests FDA Feedback on Neurostimulation Device
NuVasive to Open International Operations Center in Ireland: 5 Things to Know
Intuitive Surgical Begins Direct Sales to Japan

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.